Massachusetts Financial Services Co. MA Sells 41 Shares of Chemed Co. (NYSE:CHE)

Massachusetts Financial Services Co. MA reduced its position in Chemed Co. (NYSE:CHE) by 0.0% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 200,686 shares of the company’s stock after selling 41 shares during the period. Massachusetts Financial Services Co. MA’s holdings in Chemed were worth $120,606,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently modified their holdings of the company. Connor Clark & Lunn Investment Management Ltd. purchased a new position in Chemed in the third quarter worth about $3,835,000. Commerce Bank lifted its stake in shares of Chemed by 0.6% in the 3rd quarter. Commerce Bank now owns 6,207 shares of the company’s stock worth $3,730,000 after purchasing an additional 40 shares during the period. B. Metzler seel. Sohn & Co. Holding AG bought a new position in shares of Chemed in the 3rd quarter worth approximately $310,000. Pathstone Holdings LLC boosted its holdings in shares of Chemed by 6.0% in the third quarter. Pathstone Holdings LLC now owns 3,694 shares of the company’s stock worth $2,220,000 after buying an additional 210 shares during the last quarter. Finally, Thrivent Financial for Lutherans grew its position in Chemed by 25.3% during the third quarter. Thrivent Financial for Lutherans now owns 146,017 shares of the company’s stock valued at $87,752,000 after buying an additional 29,445 shares during the period. Institutional investors own 95.85% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have weighed in on CHE shares. Royal Bank of Canada decreased their price target on shares of Chemed from $697.00 to $633.00 and set an “outperform” rating on the stock in a research report on Tuesday, November 5th. StockNews.com downgraded Chemed from a “buy” rating to a “hold” rating in a research report on Friday.

Chemed Trading Up 1.4 %

Chemed stock opened at $570.96 on Friday. Chemed Co. has a 12-month low of $523.33 and a 12-month high of $654.62. The firm has a market capitalization of $8.59 billion, a price-to-earnings ratio of 28.85, a P/E/G ratio of 2.39 and a beta of 0.46. The firm has a 50 day moving average of $579.08 and a 200 day moving average of $565.16.

Chemed (NYSE:CHE) last announced its quarterly earnings data on Tuesday, October 29th. The company reported $5.64 EPS for the quarter, missing the consensus estimate of $5.76 by ($0.12). The firm had revenue of $606.18 million for the quarter, compared to the consensus estimate of $612.22 million. Chemed had a net margin of 12.69% and a return on equity of 27.86%. The firm’s revenue for the quarter was up 7.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $5.32 earnings per share. On average, analysts predict that Chemed Co. will post 21.43 EPS for the current year.

Chemed Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 6th. Stockholders of record on Monday, November 18th will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.35%. The ex-dividend date of this dividend is Monday, November 18th. Chemed’s dividend payout ratio (DPR) is 10.11%.

Insider Buying and Selling

In related news, Director George J. Walsh III sold 400 shares of the firm’s stock in a transaction on Thursday, September 26th. The shares were sold at an average price of $597.47, for a total transaction of $238,988.00. Following the completion of the transaction, the director now directly owns 3,046 shares of the company’s stock, valued at approximately $1,819,893.62. This trade represents a 11.61 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction on Thursday, September 26th. The shares were sold at an average price of $598.81, for a total transaction of $1,197,620.00. Following the completion of the sale, the chief executive officer now owns 103,735 shares in the company, valued at approximately $62,117,555.35. This represents a 1.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 4,113 shares of company stock worth $2,411,905. 3.32% of the stock is owned by corporate insiders.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.